VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) shares dropped 13.6% during mid-day trading on Tuesday . The company traded as low as C$0.10 and last traded at C$0.10. Approximately 570,496 shares were traded during mid-day trading, an increase of 339% from the average session volume of 129,831 shares. The stock had previously closed at C$0.11.
VentriPoint Diagnostics Stock Down 13.6%
The company has a quick ratio of 6.67, a current ratio of 0.08 and a debt-to-equity ratio of -63.20. The business has a 50-day simple moving average of C$0.13 and a two-hundred day simple moving average of C$0.12. The stock has a market capitalization of C$17.83 million, a P/E ratio of -4.75 and a beta of -0.29.
VentriPoint Diagnostics Company Profile
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers. The company also provides VMS+ software, a 2D and 3D ultrasound models. In addition, it develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging, and cardiotoxicity in oncology patients.
Featured Stories
- Five stocks we like better than VentriPoint Diagnostics
- Apple and Broadcom Forge a Decade-Long Silicon Fortress
- SK Hynix’s Nasdaq Listing Could Reset the AI Memory Trade
- The AI Chip Sell-Off Looks Scary, But the Real Story May Be Liquidity
- Palantir’s CEO Just Called Out OpenAI and Anthropic
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
